Information Journal Paper
APA:
Copy. (2018). Recombinant VP2 expressed in baculovirus and adjuvanted with TIRTLR7: a vaccine candidate against infectious bursal disease virus. COMPARATIVE CLINICAL PATHOLOGY, 27(4), 1-6. SID. https://sid.ir/paper/733537/en
Vancouver:
Copy. Recombinant VP2 expressed in baculovirus and adjuvanted with TIRTLR7: a vaccine candidate against infectious bursal disease virus. COMPARATIVE CLINICAL PATHOLOGY[Internet]. 2018;27(4):1-6. Available from: https://sid.ir/paper/733537/en
IEEE:
Copy, “Recombinant VP2 expressed in baculovirus and adjuvanted with TIRTLR7: a vaccine candidate against infectious bursal disease virus,” COMPARATIVE CLINICAL PATHOLOGY, vol. 27, no. 4, pp. 1–6, 2018, [Online]. Available: https://sid.ir/paper/733537/en